CD14, new aspects of ligand and signal diversity

Microbes and Infection

Volumn 2, Issue 3, 2000, Pages 295-304

  Landmann, Regine ^a   Müller, Beat ^b   Zimmerli, Werner ^b  

^a Univ H   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

CD14; Lipopolysaccharide; Signaling

Indexed keywords

ANTIBODY; CD14 ANTIGEN; CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPID; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0343619375     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00298-7     Document Type: Review

References (60)

1. Goyert S.M., Ferrero E., Rettig W.J., Yenamandra A.K., Obata F., LeBeau M.M. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science. 239:1988;497-500.
2. Wang P.Y., Kitchens R.L., Munford R.S. Bacterial lipopolysaccharide binds to CD14 in low-density domains of the monocyte-macrophage plasma membrane. J. Inflamm. 47:1995;126-137.
3. Yang R.B., Mark M.R., Gurney A.L., Godowski P.J. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J. Immunol. 163:1999;639-643.
4. Bazil V., Baudys M., Hilgert I., Stefanova I., Low M.G., Zbrozek J., Horejsi V. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol. Immunol. 26:1989;657-662.
5. Bufler P., Stiegler G., Schuchmann M., Hess S., Krager C., Stelter F., Eckerskorn C., SchÅtt C., Engelmann H. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur. J. Immunol. 25:1995;604-610.
6. Landmann R., Reber A.M., Sansano S., Zimmerli W. Function of soluble CD14 in serum from patients with septic shock. J. Infect. Dis. 173:1996;661-668.
7. Cauwels A., Frei K., Sansano S., Fearns C., Ulevitch R., Zimmerli W., Landmann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J. Immunol. 162:1999;4762-4772.
8. Landmann R., Ludwig C., Obrist R., Obrecht J.P. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J. Cell. Biochem. 47:1991;317-329.
9. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:1995;10482-10488.
10. Gallay P., Jongeneel C.V., Barras C., Burnier M., Baumgartner J.D., Glauser M.P., Heumann D. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J. Immunol. 150:1993;5086-5093.
11. McGinley M.D., Narhi L.O., Kelley M.J., Davy E., Robinson J., Rohde M.F., Wright S.D., Lichenstein H.S. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J. Biol. Chem. 270:1995;5213-5218.
12. Stelter F., Bernheiden M., Menzel R., Jack R.S., Witt S., Fan X., Pfister M., Schutt C. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli, Eur. J. Biochem. 243:1997;100-109.
13. Pugin J., Heumann D., Tomasz A., Kravchenko V., Akamatsu Y., Nishijma M., Glauser M., Tobias P., Ulevitch R. CD14 is a pattern recognition receptor. Immunity. 1:1994;509-516.
14. Tapping R.I., Tobias P.S. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J. Biol. Chem. 272:1997;23157-23164.
15. Ulmer A.J., Salmalouti V.T., Rietschel E.T., Flad H.D., Dziarsky R. CD14, an innate immune receptor for various bacterial cell wall components. Brade H, Opal S, Vogel S, Morrison D. Endotoxin in Health and Disease. 1999;463-471 Dekker, New York.
16. Wang P.Y., Kitchens R.L., Munford R.S. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273:1998;24309-24313.
17. Yu B., Hailman E., Wright S.D. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin Invest. 99:1997;315-324.
18. Janeway C.A. Jr. Presidential Address to The American Association of Immunologists. The road less traveled by: the role of innate immunity in the adaptive immune response. J. Immunol. 161:1998;539-544.
19. Kitchens R.L., Munford R.S. CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J. Immunol. 160:1998;1920-1928.
20. Gegner J.A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270:1995;5320-5325.
21. Pugin J., Kravchenko V.V., Lee J.D., Kline L., Ulevitch R.J., Tobias P.S. Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14. Infect Immun. 66:1998;1174-1180.
22. Lee J., Kravchenko V., Kirkland T., Han J., Mackman N., Moriarty A., Leturcq D., Tobias P., Ulevitch R. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc. Natl. Acad. Sci. USA. 90:1993;9930-9934.
23. Kirschning C.J., Wesche H., Merrill Ayres T., Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. M. 188:1998;2091-2097.
24. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling [see comments]. Nature. 395:1998;284-288.
25. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:1999;10689-10692.
26. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
27. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:1999;732-736.
28. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
29. Downey J.S., Han J. Cellular activation mechanisms in septic shock. Front Biosci. 3:1998;468-476.
30. Sweet M.J., Hume D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60:1996;8-26.
31. Dziarski R., Jin Y.P., Gupta D. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J. Infect. Dis. 174:1996;777-785.
32. Arditi M., Zhou J., Torres M., Durden D.L., Stins M., Kim K.S. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J. Immunol. 155:1995;3994-4003.
33. Geppert T.D., Whitehurst C.E., Thompson P., Beutler B. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol. M. 1:1994;93-103.
34. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
35. Meng F., Lowell C.A. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. M. 185:1997;1661-1670.
36. Delude R.L., Fenton M.J., Savedra R. Jr, Perera P.Y., Vogel S.N., Thieringer R., Golenbock D.T. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. J. Biol. Chem. 269:1994;22253-22260.
37. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
38. Ulevitch R.J., Tobias P.S. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:1999;19-22.
39. Lee J.D., Kato K., Tobias P.S., Kirkland T.N., Ulevitch R.J. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. M. 175:1992;1697-1705.
40. Pugin J., SchÅrer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90:1993;2744-2748.
41. Haziot A., Rong G.W., Bazil V., Silver J., Goyert S.M. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor- alpha production by cells in whole blood. J. Immunol. 152:1994;5868-5876.
42. Haziot A., Rong G.W., Lin X.Y., Silver J., Goyert S.M. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154:1995;6529-6532.
43. Wooten R.M., Morrison T.B., Weis J.H., Wright S.D., Thieringer R., Weis J.J. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:1998;5485-5492.
44. Sellati T.J., Bouis D.A., Kitchens R.L., Darveau R.P., Pugin J., Ulevitch R.J., Gangloff S.C., Goyert S.M., Norgard M.V., Radolf J.D. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160:1998;5455-5464.
45. Ferrero E., Jiao D., Tsuberi B.Z., Tesio L., Rong G.W., Haziot A., Goyert S.M. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:1993;2380-2384.
46. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of Gram- negative bacteria in CD14-deficient mice. Immunity. 4:1996;407-414.
47. Fearns C., Kravchenko V.V., Ulevitch R.J., Loskutoff D.J. Murine CD14 gene expression in vivo: Extramyeloid synthesis and regulation by lipopolysaccharide. J. Exp. M. 181:1995;857-866.
48. Stelter F., Witt S., Furll B., Jack R.S., Hartung T., Schutt C. Different efficacy of soluble CD14 treatment in high- and low-dose LPS models. Eur. J. Clin. Invest. 28:1998;205-213.
49. Medvedev A.E., Flo T., Ingalls R.R., Golenbock D.T., Teti G., Vogel S.N., Espevik T. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160:1998;4535-4542.
50. Ziegler-Heitbrock H.W., Ulevitch R.J. CD14: cell surface receptor and differentiation marker [see comments]. Immunol. Today. 14:1993;121-125.
51. Detmers P.A., Zhou D., Powell D., Lichenstein H., Kelley M., Pironkova R. Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase. J. Immunol. 155:1995;2085-2095.
52. Watanabe A., Takeshita A., Kitano S., Hanazawa S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect. Immun. 64:1996;4488-4494.
53. Kruger C., Schutt C., Obertacke U., Joka T., Muller F.E., Knoller J., Koller M., Konig W., Schonfeld W. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:1991;297-301.
54. Wenisch C., Wenisch H., Parschalk B., Vanijanonta S., Burgmann H., Exner M., Zedwitz-Liebenstein K., Thalhammer F., Georgopoulos A., Graninger W., Looareesuwan S. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin. Exp. Immunol. 105:1996;74-78.
55. Nockher W.A., Bergmann L., Scherberich J.E. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98:1994;369-374.
56. Pforte A., Schiessler A., Gais P., Beer B., Ehlers M., Schutt C., Ziegler-Heitbrock H.W. Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis. Chest. 105:1994;349-354.
57. Wuthrich B., Kagi M.K., Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch. Dermatol. Res. 284:1992;339-342.
58. Pforte A., Schiessler A., Gais P., Beer B., Strobel M., Ehlers M., Schutt C., Ziegler-Heitbrock H.W. Increased expression of the monocyte differentiation antigen CD14 in extrinsic allergic alveolitis. Monaldi Arch. Chest. Dis. 48:1993;607-612.
59. Martin T.R., Rubenfeld G., Steinberg K.P., Hudson L.D., Raghu G., Moriarty A.M., Leturcq D.J., Tobias P.S., Ulevitch R.J. Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest. 105:1994;55S-56S.
60. Dooper I.M., Hoitsma A.J., Maass C.N., Assmann K.J., Tax W.J., Koene R.A., Bogman M.J. The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection. Transplantation. 58:1994;820-827.